Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2021-12-09 00:00:00 ET · period of report 2021-12-07 · accession 0001209191-21-068918 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2021-12-09	2021-12-07	RXRX	Li Dean Y	Dir	S - Sale	$20.48	-15.9K	1.32M	-1%	-$325.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-12-07	S	D	1,000	$21.06	1,315,000	I By Dean Y. Li 2021 GRAT	—	—	(F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $21.03 to $21.11 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
2	Common	Class A Common Stock	2021-12-07	S	D	14,900	$20.44	1,316,000	I By Dean Y. Li 2021 GRAT	—	—	(F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.01 to $20.995 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.